Search Results
(±)-Hexanoylcarnitine chloride 10mg | ≥95%
Musechem
(±)-Hexanoylcarnitine chloride Please inquire | ≥98%
BOC Sciences
(±)-Hexanoylcarnitine chloride is an intermediate in lipid metabolism and a homolog of acetylcarnitine chloride.
More Information Supplier Page(±)-Hexanoylcarnitine chloride 5 mg | Purity Not Available
TargetMol

(±)-Hexanoylcarnitine chloride is a fatty acid metabolite that breaks down fatty acids into small compounds that can be utilized by the body. (±)-Hexanoylcarnitine chloride can be used as a biomarker by being specific for rat skeletal muscle toxicity.
More Information Supplier Page(±)-Hexanoylcarnitine chloride 10 mg | Purity Not Available
TargetMol

(±)-Hexanoylcarnitine chloride is a fatty acid metabolite that breaks down fatty acids into small compounds that can be utilized by the body. (±)-Hexanoylcarnitine chloride can be used as a biomarker by being specific for rat skeletal muscle toxicity.
More Information Supplier Page(±)-Hexanoylcarnitine chloride 25 mg | Purity Not Available
TargetMol

(±)-Hexanoylcarnitine chloride is a fatty acid metabolite that breaks down fatty acids into small compounds that can be utilized by the body. (±)-Hexanoylcarnitine chloride can be used as a biomarker by being specific for rat skeletal muscle toxicity.
More Information Supplier Page(±)-Hexanoylcarnitine chloride 50 mg | Purity Not Available
TargetMol

(±)-Hexanoylcarnitine chloride is a fatty acid metabolite that breaks down fatty acids into small compounds that can be utilized by the body. (±)-Hexanoylcarnitine chloride can be used as a biomarker by being specific for rat skeletal muscle toxicity.
More Information Supplier Page(±)-HIP-A 10mg | Purity Not Available
APEXBIO TECHNOLOGY LLC

excitatory amino acid transporter (EAAT) blocker Membrane Transporter/Ion Channel|Glutamate (EAAT) Transporters
More Information Supplier Page(±)-HIP-A Please inquire | ≥98%
BOC Sciences
(±)-HIP-A is a potent and non-competitive excitatory amino acid transporter (EAAT) blocker. (±)-HIP-A displays no affinity for NMDA and metabotropic glutamate receptors, and weak affinity for AMPA and kainate receptors (IC50 = 43 and 8 μM, respectively). (±)-HIP-A inhibits glutamate-induced [3H]D-aspartate release (IC50 = 1.6 μM) rather than [3H]L-glutamate uptake (IC50 = 18 μM).
More Information Supplier Page